Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06381232

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

General Health Wellness

Sex eligibility

All sexes

Study type

Observational

Primary location

Viome Life Sciences

Bothell, Washington, 98011, United States

Location status: Recruiting

Location contact

Momchilo Vuyisich

CONTACT

[email protected]

425-300-6933

About this study

The analyses conducted by Viome will include, but are not limited to: genetic, transcriptomic, metabolomic, physiological, and physical. The samples collected from participants may include any of these: stool, blood, saliva, cheek swab, vaginal, breast milk/colostrum, nasal swabs or washes, and urine.

Study participants will collect the clinical samples and ship them to Viome labs or CROs (Contract Research Organizations), where they will be analyzed.

The objective of the study is to establish which foods correspond with increased wellness, and which foods correspond to decreased wellness.

The study hypothesis is that by monitoring the patterns of food intake and lifestyle parameters, in conjunction with non-invasive sample testing, personalized diet and lifestyle recommendations can be elucidated.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Anyone that resides in the US at the time of enrollment.

Exclusion criteria

  • None

Treatment and study plan

No intervention

Other

This is an observational study, there are no interventions.

Primary outcomes

  1. Molecular Determinants of Health and Disease

    Time frame: 10 years

    We measure thousands of transcript levels in multiple clinical samples. The primary outcome measures are changes in quantitative gene expression, microbial or human, as a result of transitioning from a healthy state to a disease.

Study contacts

Contact information is provided by the study sponsor or research team.

Momchilo Vuyisich, PhD

CONTACT

[email protected]

(425) 300-6933

Sponsors and collaborators

Lead sponsor

Viome

Industry

Registry information

Important dates

Study start
2018
Primary completion
2028
Study completion
2028
First posted
Apr 24, 2024
Registry last updated
Apr 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.